Paper Details

  1. Home
  2. Paper Details

Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study.

Author: BewleyA P, HofmannM A, HomeyB, KerroucheN, LaytonA M, LehmannP, MaY M, NohlgårdC, SarwerD B, SchallerM

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study found that brimonidine gel 0.33% was effective in reducing facial redness in patients with rosacea and improved patient-reported outcomes.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Facial redness contributes to impaired psychosocial functioning in rosacea patients and the only approved treatment for erythema is topical brimonidine gel 0.33%. OBJECTIVES: To evaluate patient-reported outcomes, as well as efficacy and safety, in subjects with self-perceived severe er...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054962/

データ提供：米国国立医学図書館（NLM）

Brimonidine Gel 0.33%: A Rapid Relief for Rosacea Erythema

Rosacea, a common skin condition, can cause significant distress due to persistent facial redness. This study explores the efficacy of brimonidine gel 0.33% in treating rosacea erythema, employing a randomized, double-blind, vehicle-controlled study to assess patient-reported outcomes and clinical efficacy. The research reveals that brimonidine gel 0.33% can rapidly improve patient satisfaction and control facial redness, offering a significant improvement in quality of life for individuals with rosacea.

Brimonidine Gel 0.33%: A Promising Solution for Rosacea Erythema

The study demonstrates the effectiveness of brimonidine gel 0.33% in controlling facial erythema. The results show a significant improvement in patient satisfaction with their appearance, along with a marked decrease in the severity of erythema. These findings suggest that brimonidine gel 0.33% can provide rapid and effective relief for individuals struggling with rosacea erythema.

Living with Rosacea: A Journey to Confidence

The research highlights the impact of rosacea on quality of life and the potential of brimonidine gel 0.33% to address this concern. For individuals living with rosacea, a rapid reduction in facial erythema can significantly boost confidence and improve overall well-being. The study provides a valuable tool for clinicians in managing rosacea erythema and enhancing the lives of their patients.

Dr.Camel's Conclusion

Like a camel navigating a scorching desert, individuals with rosacea often face the discomfort and embarrassment of persistent facial redness. This study offers a ray of hope, demonstrating the effectiveness of brimonidine gel 0.33% in rapidly reducing erythema and restoring confidence. This research reminds us that even in the face of challenging skin conditions, there are solutions that can lead to a more comfortable and fulfilling life.

Date :
  1. Date Completed 2016-10-14
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

26416154

DOI: Digital Object Identifier

PMC5054962

Related Literature

Article Analysis
・Effective treatment of rosacea
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.